Polomar Health Services, Inc. SEC filings PMHS
Polomar Health Services, Inc. has 150 filings in SEC EDGAR's recent list, going back to Sep 30, 2003. Its latest annual report, Form 10-K, was filed on May 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (restatement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Restatement
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 19, 2026 |
| EFFECT | Filing | Sep 23, 2026 | — |
| POS AM | Filing | Sep 23, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change, Bylaw or fiscal year change
|
Jul 30, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 17, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jul 6, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Agreement ended
|
Jun 15, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | Jun 1, 2026 | Mar 31, 2026 |
| NT 10-Q | Filing | May 18, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 15, 2026 | May 15, 2026 |
| 10-K | Annual report | May 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Agreement ended
|
Apr 29, 2026 | Apr 23, 2026 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| DEFM14C | Filing | Mar 12, 2026 | — |
| DEF 14C | Information statement | Feb 17, 2026 | Feb 17, 2026 |
| PRER14C | Filing | Feb 17, 2026 | — |
| PRE 14C | Filing | Feb 5, 2026 | Feb 5, 2026 |
| 424B3 | Prospectus | Dec 19, 2025 | — |
| EFFECT | Filing | Dec 12, 2025 | — |
| 8-K |
Current report
Material agreement
|
Dec 12, 2025 | Dec 12, 2025 |
| CORRESP | Letter to the SEC | Dec 11, 2025 | — |
| S-1/A | Amended registration statement | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 5, 2025 | — |
| S-1/A | Amended registration statement | Dec 5, 2025 | — |
| 10-Q | Quarterly report | Nov 25, 2025 | Sep 30, 2025 |
| NT 10-Q | Filing | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 14, 2025 | Oct 8, 2025 |
| UPLOAD | Letter from the SEC | Sep 19, 2025 | — |
| S-1 | Registration statement | Sep 15, 2025 | — |
| 8-K |
Current report
Material agreement
|
Aug 29, 2025 | Aug 29, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| NT 10-Q | Filing | Aug 15, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 29, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 25, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Bylaw or fiscal year change
|
Jul 9, 2025 | Jul 9, 2025 |
| 10-Q | Quarterly report | Jun 30, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | Jun 3, 2025 | — |
| 10-K | Annual report | May 22, 2025 | Dec 31, 2024 |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| NT 10-Q | Filing | May 16, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 16, 2025 | Apr 16, 2025 |
| CORRESP | Letter to the SEC | Apr 1, 2025 | — |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 17, 2025 | Mar 17, 2025 |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| CORRESP | Letter to the SEC | Mar 7, 2025 | — |
| 10-Q/A | Amended quarterly report | Mar 7, 2025 | Sep 30, 2024 |
| 8-K |
Current report
Restatement
|
Mar 5, 2025 | Feb 28, 2025 |
| UPLOAD | Letter from the SEC | Feb 13, 2025 | — |
| 8-K |
Current report
Material agreement
|
Jan 14, 2025 | Jan 9, 2025 |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 15, 2024 | Sep 30, 2024 |
| 8-K/A |
Amended current report
Material agreement, New debt
|
Nov 12, 2024 | Sep 30, 2024 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Oct 25, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 17, 2024 | Oct 10, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change
|
Oct 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Sep 20, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 21, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| DEF 14C | Information statement | Aug 1, 2024 | Aug 1, 2024 |
| UPLOAD | Letter from the SEC | Jul 31, 2024 | — |
| PRER14C | Filing | Jul 25, 2024 | — |
| CORRESP | Letter to the SEC | Jul 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2024 | Jul 18, 2024 |
| PRE 14C | Filing | Jul 17, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 17, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 5, 2024 | Jun 29, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2024 | Jun 28, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 15, 2024 | Dec 31, 2023 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 16, 2024 | Feb 12, 2024 |
| SC 14F1 | Filing | Jan 29, 2024 | — |
| 8-K |
Current report
Change in control, Officer or director change
|
Jan 4, 2024 | Dec 29, 2023 |
| 10-Q | Quarterly report | Nov 15, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 13, 2023 | Oct 9, 2023 |
| 10-Q | Quarterly report | Aug 23, 2023 | Jun 30, 2023 |
| UPLOAD | Letter from the SEC | Aug 3, 2023 | — |
| 10-12G/A | Filing | Jul 25, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| 10-12G/A | Filing | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2023 | — |
| 10-12G | Filing | May 31, 2023 | — |
| 15-15D | Healthmed services form 15, 04.01.11 | Apr 5, 2011 | — |
| NT 10-K | Healthmed services 12b-25 extension for 10k, 12.31.10 | Mar 31, 2011 | Dec 31, 2010 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change in control, Officer or director change
|
Mar 28, 2011 | Mar 23, 2011 |
| 10-K/A | Amended annual report | Feb 18, 2011 | Dec 31, 2009 |
| 10-K/A | Amended annual report | Feb 9, 2011 | Dec 31, 2009 |
| UPLOAD | Letter from the SEC | Feb 1, 2011 | — |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2011 | Jan 17, 2011 |
| 10-K/A | Amended annual report | Jan 12, 2011 | Dec 31, 2009 |
| CORRESP | Letter to the SEC | Jan 12, 2011 | — |
| 10-Q/A | Amended quarterly report | Jan 12, 2011 | Jun 30, 2010 |
| 10-K/A | Amended annual report | Jan 12, 2011 | Dec 31, 2009 |
| CORRESP | Letter to the SEC | Jan 12, 2011 | — |
| CORRESP | Letter to the SEC | Dec 23, 2010 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 23, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | Dec 21, 2010 | Sep 30, 2010 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 18, 2010 | Nov 16, 2010 |
| NT 10-Q | Healthmed services 12b-25 extension for 10q, 09.30.10 | Nov 12, 2010 | Sep 30, 2010 |
| UPLOAD | Letter from the SEC | Nov 3, 2010 | — |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2010 | Aug 30, 2010 |
| 10-Q | Quarterly report | Aug 23, 2010 | Jun 30, 2010 |
| NT 10-Q | Form 12b-25 of healthmed services, ltd. | Aug 16, 2010 | Jun 30, 2010 |
| 8-K |
Current report
Auditor change
|
Aug 13, 2010 | Aug 11, 2010 |
| EFFECT | Filing | Aug 10, 2010 | — |
| CORRESP | Letter to the SEC | Jul 30, 2010 | — |
| POS AM | Filing | Jul 28, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2010 | — |
| POS AM | Filing | Jul 14, 2010 | — |
| RW | Filing | Jul 14, 2010 | — |
| S-1/A | Amended registration statement | Jun 29, 2010 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 10, 2010 | Jun 10, 2010 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2010 | Jun 1, 2010 |
| 10-Q | Quarterly report | May 17, 2010 | Mar 31, 2010 |
| 10-K | Annual report | Mar 31, 2010 | Dec 31, 2009 |
| 10-Q | Quarterly report | Nov 16, 2009 | Sep 30, 2009 |
| 8-K/A |
Amended current report
Auditor change
|
Sep 9, 2009 | Aug 7, 2009 |
| 8-K |
Current report
Auditor change
|
Aug 18, 2009 | Aug 7, 2009 |
| 10-Q | Quarterly report | Aug 11, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | May 14, 2009 | Mar 31, 2009 |
| 10-K | Annual report | Mar 11, 2009 | Dec 31, 2008 |
| 10-Q | Quarterly report | Nov 10, 2008 | Sep 30, 2008 |
| 10-Q/A | Amended quarterly report | Oct 7, 2008 | Jun 30, 2008 |
| 10-Q | Quarterly report | Aug 19, 2008 | Jun 30, 2008 |
| NT 10-Q | Notification of late filing | Aug 15, 2008 | Jun 30, 2008 |
| EFFECT | Filing | Aug 4, 2008 | — |
| S-1 | Registration statement | Jul 21, 2008 | — |
| REGDEX | Auto-generated paper document | Sep 30, 2003 | — |
Showing 139 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMHS (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Palm Harbor, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1265521
- Former names
- Trustfeed Corp. (until Oct 11, 2024); HEALTHMED SERVICES LTD (until Apr 5, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.